BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Nov. 10, 2010
View Archived Issues
Celtic Fund May not Reach $700M as Final Closing Nears
LONDON – After stalling during the financial crisis, Celtic Therapeutic Holdings LP is coming to the end of marketing its first fund and expects to have the final closing by the end of the year. (BioWorld International)
Read More
Wilex Acquiring Heidelberg Pharma for $27M in Stock
Read More
Immune Mechanism Promises New Approach to Antivirals
Read More
Cosmo Poised for Filings for Ulcerative Colitis Drug
Read More
Zealand Pharma Seeking $126M in Danish IPO
Read More
Other News To Note
Read More